Annual FCF
-$113.85 M
-$27.31 M-31.56%
December 1, 2024
Summary
- As of February 22, 2025, ORIC annual free cash flow is -$113.85 million, with the most recent change of -$27.31 million (-31.56%) on December 1, 2024.
- During the last 3 years, ORIC annual FCF has fallen by -$53.37 million (-88.24%).
- ORIC annual FCF is now -436.83% below its all-time high of -$21.21 million, reached on December 31, 2018.
Performance
ORIC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
N/A
December 1, 2024
Summary
- ORIC quarterly free cash flow is not available.
Performance
ORIC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
N/A
December 1, 2024
Summary
- ORIC TTM free cash flow is not available.
Performance
ORIC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ORIC Free Cash Flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -31.6% | - | - |
3 y3 years | -88.2% | - | - |
5 y5 years | -368.5% | - | - |
ORIC Free Cash Flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -88.2% | at low | ||||
5 y | 5-year | -368.5% | at low | ||||
alltime | all time | -436.8% | at low |
ORIC Pharmaceuticals Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$113.85 M(+31.6%) | - | - |
Sep 2024 | - | -$29.21 M(+12.5%) | -$109.90 M(+9.5%) |
Jun 2024 | - | -$25.96 M(-14.6%) | -$100.41 M(+4.6%) |
Mar 2024 | - | -$30.40 M(+25.0%) | -$96.00 M(+10.9%) |
Dec 2023 | -$86.54 M(+12.1%) | -$24.33 M(+23.3%) | -$86.54 M(+11.2%) |
Sep 2023 | - | -$19.72 M(-8.5%) | -$77.83 M(+0.0%) |
Jun 2023 | - | -$21.55 M(+2.9%) | -$77.83 M(+4.2%) |
Mar 2023 | - | -$20.94 M(+34.1%) | -$74.72 M(-3.2%) |
Dec 2022 | -$77.22 M(+27.7%) | -$15.62 M(-20.8%) | -$77.22 M(-1.4%) |
Sep 2022 | - | -$19.72 M(+6.9%) | -$78.28 M(+10.4%) |
Jun 2022 | - | -$18.44 M(-21.3%) | -$70.93 M(+3.0%) |
Mar 2022 | - | -$23.44 M(+40.6%) | -$68.84 M(+13.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$60.48 M(+31.7%) | -$16.67 M(+34.7%) | -$60.48 M(-2.5%) |
Sep 2021 | - | -$12.38 M(-24.3%) | -$62.04 M(+4.6%) |
Jun 2021 | - | -$16.35 M(+8.4%) | -$59.30 M(+12.4%) |
Mar 2021 | - | -$15.08 M(-17.3%) | -$52.73 M(+14.8%) |
Dec 2020 | -$45.94 M(+89.0%) | -$18.24 M(+89.4%) | -$45.94 M(+31.6%) |
Sep 2020 | - | -$9.63 M(-1.6%) | -$34.90 M(+13.1%) |
Jun 2020 | - | -$9.79 M(+18.1%) | -$30.85 M(+14.5%) |
Mar 2020 | - | -$8.28 M(+15.0%) | -$26.95 M(+10.9%) |
Dec 2019 | -$24.30 M(+14.6%) | -$7.20 M(+29.1%) | -$24.30 M(+42.1%) |
Sep 2019 | - | -$5.58 M(-5.2%) | -$17.10 M(+48.4%) |
Jun 2019 | - | -$5.89 M(+4.5%) | -$11.52 M(+104.5%) |
Mar 2019 | - | -$5.63 M | -$5.63 M |
Dec 2018 | -$21.21 M | - | - |
FAQ
- What is ORIC Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for ORIC Pharmaceuticals?
- What is ORIC Pharmaceuticals annual FCF year-on-year change?
- What is the all time high quarterly FCF for ORIC Pharmaceuticals?
- What is the all time high TTM FCF for ORIC Pharmaceuticals?
What is ORIC Pharmaceuticals annual free cash flow?
The current annual FCF of ORIC is -$113.85 M
What is the all time high annual FCF for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high annual free cash flow is -$21.21 M
What is ORIC Pharmaceuticals annual FCF year-on-year change?
Over the past year, ORIC annual free cash flow has changed by -$27.31 M (-31.56%)
What is the all time high quarterly FCF for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high quarterly free cash flow is -$5.58 M
What is the all time high TTM FCF for ORIC Pharmaceuticals?
ORIC Pharmaceuticals all-time high TTM free cash flow is -$5.63 M